Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Arends

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Rheumatology International|July 16, 2024
Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional studyHelma J Hinkema, Johanna Westra, Suzanne Arends, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practiceLiseth de Wolff, Freke R Wink, Hendrika Bootsma, et al.
ARP Rheumatology|January 4, 2024
Translation and cross-cultural adaptation of the modified Short QUestionnaire to Assess Health-enhancing physical activity (mSQUASH) into TurkishGizem Ayan, Sofia Ramiro, Fernando M Santos, et al.
Plos One|March 24, 2023
After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitisMark Siderius, Anneke Spoorenberg, Frans G M Kroese, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndromeLiseth de Wolff, Suzanne Arends, Elena Pontarini, et al.
Current Opinion in Rheumatology|March 16, 2012
Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitisSuzanne Arends, Eveline van der Veer, Cees G M Kallenberg, et al.
Plos One|February 19, 2013
Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) QuestionnaireFreke Wink, Suzanne Arends, Stephen P McKenna, et al.
Arthritis Research & Therapy|August 9, 2023
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritisAngelique Rondags, Laura van Marle, Barbara Horváth, et al.
Lupus Science & Medicine|November 19, 2021
Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohortWietske Lambers, Suzanne Arends, Caroline Roozendaal, et al.
Clinical and Experimental Rheumatology|October 7, 2020
10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren's syndrome or sicca symptoms in daily clinical practiceRada V Moerman, Suzanne Arends, Esther Mossel, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Rheumatology International|July 16, 2024
Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional studyHelma J Hinkema, Johanna Westra, Suzanne Arends, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial spondyloarthritis in daily clinical practiceLiseth de Wolff, Freke R Wink, Hendrika Bootsma, et al.
ARP Rheumatology|January 4, 2024
Translation and cross-cultural adaptation of the modified Short QUestionnaire to Assess Health-enhancing physical activity (mSQUASH) into TurkishGizem Ayan, Sofia Ramiro, Fernando M Santos, et al.
Plos One|March 24, 2023
After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitisMark Siderius, Anneke Spoorenberg, Frans G M Kroese, et al.
Clinical and Experimental Rheumatology|November 19, 2021
Development and performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), consisting of frequently active clinical domains, in two randomised controlled trials in primary Sjögren's syndromeLiseth de Wolff, Suzanne Arends, Elena Pontarini, et al.
Current Opinion in Rheumatology|March 16, 2012
Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitisSuzanne Arends, Eveline van der Veer, Cees G M Kallenberg, et al.
Plos One|February 19, 2013
Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) QuestionnaireFreke Wink, Suzanne Arends, Stephen P McKenna, et al.
Arthritis Research & Therapy|August 9, 2023
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritisAngelique Rondags, Laura van Marle, Barbara Horváth, et al.
Lupus Science & Medicine|November 19, 2021
Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohortWietske Lambers, Suzanne Arends, Caroline Roozendaal, et al.
Clinical and Experimental Rheumatology|October 7, 2020
10-year follow-up of patients with rheumatoid arthritis and secondary Sjögren's syndrome or sicca symptoms in daily clinical practiceRada V Moerman, Suzanne Arends, Esther Mossel, et al.
Pageof 14